相似文献
1
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae.
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12391-6. doi: 10.1073/pnas.182380799. Epub 2002 Aug 28.
2
Comparative genomic analysis and identification of pathogenicity islands of hypervirulent ST-17 Streptococcus agalactiae Brazilian strain.
Infect Genet Evol. 2020 Jun;80:104195. doi: 10.1016/j.meegid.2020.104195. Epub 2020 Jan 15.
3
Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease.
Mol Microbiol. 2002 Sep;45(6):1499-513. doi: 10.1046/j.1365-2958.2002.03126.x.
4
Comparative genome analysis identifies two large deletions in the genome of highly-passaged attenuated Streptococcus agalactiae strain YM001 compared to the parental pathogenic strain HN016.
BMC Genomics. 2015 Nov 4;16:897. doi: 10.1186/s12864-015-2026-y.
5
Serotype IV Streptococcus agalactiae ST-452 has arisen from large genomic recombination events between CC23 and the hypervirulent CC17 lineages.
Sci Rep. 2016 Jul 14;6:29799. doi: 10.1038/srep29799.
6
Genomic comparison between pathogenic Streptococcus agalactiae isolated from Nile tilapia in Thailand and fish-derived ST7 strains.
Infect Genet Evol. 2015 Dec;36:307-314. doi: 10.1016/j.meegid.2015.10.009. Epub 2015 Oct 9.
7
Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome".
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13950-5. doi: 10.1073/pnas.0506758102. Epub 2005 Sep 19.
8
Genomic diversity and evolution within the species Streptococcus agalactiae.
Microbes Infect. 2006 Apr;8(5):1227-43. doi: 10.1016/j.micinf.2005.11.010. Epub 2006 Jan 19.
9
Molecular Evolution of Clinical Pathogenic Streptococci.
Curr Issues Mol Biol. 2019;32:561-600. doi: 10.21775/cimb.032.561. Epub 2019 Jun 5.
10
First report of Streptococcus agalactiae isolated from a healthy captive sichuan golden snub-nosed monkey (Rhinopithecus roxellana) in China.
Microb Pathog. 2024 Oct;195:106907. doi: 10.1016/j.micpath.2024.106907. Epub 2024 Aug 30.
引用本文的文献
1
The virulence regulator CovR boosts CRISPR-Cas9 immunity in Group B Streptococcus.
Nat Commun. 2025 Jul 1;16(1):5678. doi: 10.1038/s41467-025-60871-6.
2
Group B growth in human urine is associated with asymptomatic bacteriuria rather than urinary tract infection and is unaffected by iron sequestration.
Microbiology (Reading). 2025 Feb;171(2). doi: 10.1099/mic.0.001533.
3
Virulence and pathogenicity of group B : Virulence factors and their roles in perinatal infection.
Virulence. 2025 Dec;16(1):2451173. doi: 10.1080/21505594.2025.2451173. Epub 2025 Jan 23.
4
Modern microbiology: Embracing complexity through integration across scales.
Cell. 2024 Sep 19;187(19):5151-5170. doi: 10.1016/j.cell.2024.08.028.
5
Environmental and genetic regulation of Streptococcus pneumoniae galactose catabolic pathways.
Nat Commun. 2024 Jun 17;15(1):5171. doi: 10.1038/s41467-024-49619-w.
6
Type VII secretion system and its effect on group B Streptococcus virulence in isolates obtained from newborns with early onset disease and colonized pregnant women.
Front Cell Infect Microbiol. 2023 Jul 21;13:1168530. doi: 10.3389/fcimb.2023.1168530. eCollection 2023.
7
Heterogeneity of the group B streptococcal type VII secretion system and influence on colonization of the female genital tract.
Mol Microbiol. 2023 Aug;120(2):258-275. doi: 10.1111/mmi.15115. Epub 2023 Jun 26.
8
Group B Streptococcus CRISPR1 Typing of Maternal, Fetal, and Neonatal Infectious Disease Isolates Highlights the Importance of CC1 in Fetal Death.
Microbiol Spectr. 2023 Aug 17;11(4):e0522122. doi: 10.1128/spectrum.05221-22. Epub 2023 Jun 21.
9
Gamma-Irradiated Non-Capsule Group B Streptococcus Promotes T-Cell Dependent Immunity and Provides a Cross-Protective Reaction.
Pharmaceuticals (Basel). 2023 Feb 20;16(2):321. doi: 10.3390/ph16020321.
10
Group B streptococcus virulence factors associated with different clinical syndromes: Asymptomatic carriage in pregnant women and early-onset disease in the newborn.
Front Microbiol. 2023 Feb 13;14:1093288. doi: 10.3389/fmicb.2023.1093288. eCollection 2023.
本文引用的文献
1
Proteins PblA and PblB of Streptococcus mitis, which promote binding to human platelets, are encoded within a lysogenic bacteriophage.
Infect Immun. 2001 Oct;69(10):6186-92. doi: 10.1128/IAI.69.10.6186-6192.2001.
2
Horizontal gene transfer and host specificity of beta-haemolytic streptococci: the role of a putative composite transposon containing scpB and lmb.
Mol Microbiol. 2001 Aug;41(4):925-35. doi: 10.1046/j.1365-2958.2001.02563.x.
3
Complete genome sequence of a virulent isolate of Streptococcus pneumoniae.
Science. 2001 Jul 20;293(5529):498-506. doi: 10.1126/science.1061217.
4
Adenylate kinase as a virulence factor of Pseudomonas aeruginosa.
J Bacteriol. 2001 Jun;183(11):3345-52. doi: 10.1128/JB.183.11.3345-3352.2001.
5
Complete genome sequence of an M1 strain of Streptococcus pyogenes.
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4658-63. doi: 10.1073/pnas.071559398.
6
Mutually exclusive distribution of IS1548 and GBSi1, an active group II intron identified in human isolates of group B streptococci.
J Bacteriol. 2001 Apr;183(8):2560-9. doi: 10.1128/JB.183.8.2560-2569.2001.
7
Complete genome sequence of Caulobacter crescentus.
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4136-41. doi: 10.1073/pnas.061029298. Epub 2001 Mar 20.
8
Genetic loci of Streptococcus mitis that mediate binding to human platelets.
Infect Immun. 2001 Mar;69(3):1373-80. doi: 10.1128/IAI.69.3.1373-1380.2001.
9
Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus.
Mol Microbiol. 2001 Jan;39(2):236-47. doi: 10.1046/j.1365-2958.2001.02211.x.
10
TIGRFAMs: a protein family resource for the functional identification of proteins.
Nucleic Acids Res. 2001 Jan 1;29(1):41-3. doi: 10.1093/nar/29.1.41.
Zotero 插件